Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" report has ...

Portland, OR, May 31, 2022 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market by Product (Normal ...

(HealthDay)—Percutaneous transluminal angioplasty (PTA) seems to be safe but ineffective for patients with multiple sclerosis (MS) and chronic cerebrospinal venous insufficiency (CCSVI), according to ...

SysGalaxy Market Research has published a detailed research study based on the Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters Market. The report offers thorough information on ...

Renovascular disease is an important cause of hypertension in children and is associated with considerable increase in the risk of morbidity and mortality. In 70% of all cases of secondary ...

The global percutaneous transluminal angioplasty (PTA) balloons market was valued at approximately US$ 2.1 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.4%, ...

A minimally invasive treatment termed percutaneous transluminal coronary angioplasty (PTCA), also known as percutaneous coronary intervention (PCI), is used to unblock stenosed or blocked coronary ...

DUBLIN--(BUSINESS WIRE)--The "Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition): Analysis By Product Type (Balloon Catheters, Stents, Guidewires, Others), By Application, By End ...

HealthDay News — Percutaneous transluminal angioplasty (PTA) seems to be safe but ineffective for patients with multiple sclerosis (MS) and chronic cerebrospinal venous insufficiency (CCSVI), ...

In Panel A, a lateral angiogram of the left vertebral artery shows a high-grade (atherosclerotic) stenosis proximal to the origin of the posterior inferior cerebellar artery and delayed filling of the ...